Ledger.Open graph →
SEC Form D · filed January 15, 2019

Kleo Pharmaceuticals, Inc

Offering
$21.2M
Sold
$21.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Charles G. Drake · New York, NYDirectorDouglas G. Manion · New Haven, CTExec · DirectorRoy Prieb · New Haven, CTExec · DirectorJohn W. Childs · Waltham, MADirectorAlexander Goor · New York, NYDirectorCorson Ellis · Tysons, VADirectorTimothy Davenport · Tysons, VADirectorJoel Davidson · Luxembourg, LuxembourgExec · DirectorMatthew Boehm · Tysons, VAExec · DirectorDeclan Doogan · Stonington, CTDirectorAndrew D. Page · Mountain View, CAExec · DirectorJoe D. Carey · Mountain View, CADirectorErica J. Palsis · Mountain View, CADirectorJody Flaws · New York, NYExec · DirectorDeclan Doogan · New Haven, CTDirectorAlexander Goor · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗